======= C15orf38 ======= == Gene Information == * **Official Symbol**: ARPIN * **Official Name**: actin related protein 2/3 complex inhibitor * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=348110|348110]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q7Z6K5|Q7Z6K5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=C15orf38&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C15orf38|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615543|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Regulates actin polymerization by inhibiting the actin- nucleating activity of the Arp2/3 complex; the function is competetive with nucleation promoting factors. Participates in an incoherent feedforward loop at the lamellipodium tip where it inhibits the ARP2/2 complex in response to Rac signaling and where Rac also stimulates actin polymerization through the WAVE complex. Involved in steering cell migration by controlling its directional persistence. {ECO:0000269|PubMed:24132237}. |UPF0552| |negative regulation of lamellipodium morphogenesis| |directional locomotion| |negative regulation of lamellipodium organization| |negative regulation of actin nucleation| |regulation of lamellipodium morphogenesis| |regulation of actin nucleation| |regulation of lamellipodium organization| |negative regulation of supramolecular fiber organization| |negative regulation of cytoskeleton organization| |regulation of actin filament polymerization| |lamellipodium| |negative regulation of cell projection organization| |regulation of actin polymerization or depolymerization| |regulation of actin filament length| |regulation of protein polymerization| |negative regulation of cell migration| |regulation of actin filament organization| |negative regulation of cell motility| |negative regulation of cellular component movement| |negative regulation of locomotion| |regulation of actin cytoskeleton organization| |regulation of supramolecular fiber organization| |negative regulation of organelle organization| |regulation of cellular component size| |regulation of actin filament-based process| |regulation of protein complex assembly| |regulation of cell morphogenesis| |regulation of anatomical structure size| |regulation of cytoskeleton organization| |regulation of plasma membrane bounded cell projection organization| |negative regulation of cellular component organization| |regulation of cell projection organization| |regulation of cell migration| |regulation of cell motility| |negative regulation of developmental process| |regulation of cellular component biogenesis| |regulation of locomotion| |regulation of cellular component movement| |regulation of anatomical structure morphogenesis| |regulation of organelle organization| |locomotion| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.7| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|1.97| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12434 * **Expression level (log2 read counts)**: 3.53 {{:chemogenomics:nalm6 dist.png?nolink |}}